دورية أكاديمية
أعرض في EDS

Selenium Nanoparticles in Protecting the Brain from Stroke: Possible Signaling and Metabolic Mechanisms.

التفاصيل البيبلوغرافية
العنوان: Selenium Nanoparticles in Protecting the Brain from Stroke: Possible Signaling and Metabolic Mechanisms.
المؤلفون: Turovsky EA; Institute of Cell Biophysics of the Russian Academy of Sciences, Federal Research Center 'Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences', 142290 Pushchino, Russia., Baryshev AS; Prokhorov General Physics Institute of the Russian Academy of Sciences, 38 Vavilove st., 119991 Moscow, Russia., Plotnikov EY; A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
المصدر: Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2024 Jan 11; Vol. 14 (2). Date of Electronic Publication: 2024 Jan 11.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101610216 Publication Model: Electronic Cited Medium: Print ISSN: 2079-4991 (Print) Linking ISSN: 20794991 NLM ISO Abbreviation: Nanomaterials (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2011]-
مستخلص: Strokes rank as the second most common cause of mortality and disability in the human population across the world. Currently, available methods of treating or preventing strokes have significant limitations, primarily the need to use high doses of drugs due to the presence of the blood-brain barrier. In the last decade, increasing attention has been paid to the capabilities of nanotechnology. However, the vast majority of research in this area is focused on the mechanisms of anticancer and antiviral effects of nanoparticles. In our opinion, not enough attention is paid to the neuroprotective mechanisms of nanomaterials. In this review, we attempted to summarize the key molecular mechanisms of brain cell damage during ischemia. We discussed the current literature regarding the use of various nanomaterials for the treatment of strokes. In this review, we examined the features of all known nanomaterials, the possibility of which are currently being studied for the treatment of strokes. In this regard, the positive and negative properties of nanomaterials for the treatment of strokes have been identified. Particular attention in the review was paid to nanoselenium since selenium is a vital microelement and is part of very important and little-studied proteins, e.g., selenoproteins and selenium-containing proteins. An analysis of modern studies of the cytoprotective effects of nanoselenium made it possible to establish the mechanisms of acute and chronic protective effects of selenium nanoparticles. In this review, we aimed to combine all the available information regarding the neuroprotective properties and mechanisms of action of nanoparticles in neurodegenerative processes, especially in cerebral ischemia.
References: Biol Trace Elem Res. 2011 Dec;144(1-3):327-38. (PMID: 21633835)
Curr Pharm Des. 2011;17(18):1825-33. (PMID: 21631424)
Neuroscience. 2019 May 15;406:38-49. (PMID: 30849448)
Circ Cardiovasc Interv. 2018 Jan;11(1):e005362. (PMID: 29311286)
Cell. 2019 May 16;177(5):1262-1279.e25. (PMID: 31056284)
Int J Mol Sci. 2022 Nov 07;23(21):. (PMID: 36362436)
J Clin Biochem Nutr. 2021 Mar;68(2):123-130. (PMID: 33879963)
J Trace Elem Med Biol. 2021 Mar;64:126680. (PMID: 33242795)
ACS Nano. 2009 Nov 24;3(11):3358-68. (PMID: 19839607)
Stroke. 2018 Jan;49(1):232-235. (PMID: 29212743)
Cell. 2018 Jan 25;172(3):409-422.e21. (PMID: 29290465)
J Photochem Photobiol B. 2019 Jan;190:98-102. (PMID: 30504054)
Cell Calcium. 2018 Mar;70:76-86. (PMID: 28506443)
Metab Brain Dis. 2021 Aug;36(6):1259-1266. (PMID: 33826055)
Glia. 2011 Jun;59(6):959-72. (PMID: 21456042)
Int J Nanomedicine. 2021 Feb 04;16:775-788. (PMID: 33574665)
Drug Discov Today. 2007 Jan;12(1-2):54-61. (PMID: 17198973)
Free Radic Biol Med. 2007 Jul 15;43(2):191-201. (PMID: 17603929)
Neurosci Bull. 2020 Jul;36(7):733-760. (PMID: 32219700)
Neurol Sci. 2013 Sep;34(9):1671-8. (PMID: 23404306)
Environ Toxicol. 2023 Oct 20;:. (PMID: 37860879)
Biology (Basel). 2022 May 25;11(6):. (PMID: 35741332)
ACS Appl Mater Interfaces. 2019 Sep 25;11(38):34725-34735. (PMID: 31479233)
Arch Biochem Biophys. 2017 Feb 1;615:35-43. (PMID: 28063948)
Exp Brain Res. 2007 Jul;180(4):765-74. (PMID: 17333008)
Neuroscience. 2012 Apr 19;208:58-68. (PMID: 22640876)
Curr Neuropharmacol. 2018;16(9):1396-1415. (PMID: 29512465)
J Clin Biochem Nutr. 2020 Jan;66(1):1-7. (PMID: 32001950)
J Biol Chem. 2016 May 27;291(22):11843-51. (PMID: 27053107)
Oncogene. 2008 Oct 27;27(50):6407-18. (PMID: 18955969)
Adv Cancer Res. 2017;136:173-192. (PMID: 29054418)
ACS Nano. 2012 Feb 28;6(2):1251-9. (PMID: 22250809)
Thyroid. 2019 Nov;29(11):1669-1682. (PMID: 31359845)
Antioxidants (Basel). 2022 Jun 29;11(7):. (PMID: 35883782)
Nat Nanotechnol. 2009 Feb;4(2):126-33. (PMID: 19197316)
Part Fibre Toxicol. 2022 Aug 3;19(1):52. (PMID: 35922858)
Int J Mol Sci. 2023 Jan 26;24(3):. (PMID: 36768736)
Cell. 2016 Dec 15;167(7):1693-1704. (PMID: 27984721)
Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19;369(1654):20130598. (PMID: 25225092)
Int J Biol Macromol. 2020 Jan 1;142:265-276. (PMID: 31593732)
Neurosci Lett. 2018 Jan 1;662:189-194. (PMID: 29061397)
Biochem Pharmacol (Los Angel). 2016;5(4):. (PMID: 29888120)
Oxid Med Cell Longev. 2016;2016:1203285. (PMID: 27190572)
Antioxidants (Basel). 2022 Mar 17;11(3):. (PMID: 35326221)
Int J Mol Sci. 2023 Sep 19;24(18):. (PMID: 37762608)
Front Bioeng Biotechnol. 2022 Sep 08;10:989602. (PMID: 36159667)
J Biol Chem. 2014 Apr 4;289(14):9662-74. (PMID: 24519931)
Pharmaceutics. 2022 Dec 11;14(12):. (PMID: 36559266)
Biomolecules. 2023 May 08;13(5):. (PMID: 37238669)
Int J Mol Sci. 2021 Oct 06;22(19):. (PMID: 34639150)
Redox Biol. 2017 Aug;12:8-17. (PMID: 28212525)
Sci Rep. 2017 Jun 23;7(1):4131. (PMID: 28646143)
Int J Mol Sci. 2021 Jan 20;22(3):. (PMID: 33498364)
Front Neurosci. 2021 Feb 05;15:630016. (PMID: 33613188)
Neurosci Lett. 2021 Nov 1;764:136244. (PMID: 34530116)
Nutr Metab (Lond). 2018 Jan 22;15:7. (PMID: 29410696)
Part Fibre Toxicol. 2014 Feb 17;11:11. (PMID: 24529161)
Biochim Biophys Acta. 2013 Jul;1833(7):1625-31. (PMID: 23219860)
N Engl J Med. 2018 Dec 20;379(25):2429-2437. (PMID: 30575491)
Front Comput Neurosci. 2019 Jul 23;13:49. (PMID: 31396067)
J Neurosci. 2012 May 2;32(18):6391-410. (PMID: 22553043)
Sci Rep. 2019 Apr 15;9(1):6044. (PMID: 30988361)
Inflammopharmacology. 2020 Jun;28(3):667-695. (PMID: 32144521)
J Nutr. 2023 Nov;153(11):3164-3172. (PMID: 36963501)
Neuroscientist. 2021 Aug;27(4):355-366. (PMID: 32727285)
Biomater Sci. 2016 Feb;4(2):219-29. (PMID: 26646694)
Int J Mol Sci. 2023 Jul 30;24(15):. (PMID: 37569591)
Chem Res Toxicol. 2019 Mar 18;32(3):362-369. (PMID: 30653290)
Nanomedicine (Lond). 2013 Jul;8(7):1191-208. (PMID: 23837857)
J Nutr. 2004 Jan;134(1):157-61. (PMID: 14704310)
PLoS One. 2014 Aug 01;9(8):e103857. (PMID: 25083788)
IET Nanobiotechnol. 2021 Jun;15(4):427-440. (PMID: 34694715)
Front Neurosci. 2021 Apr 13;15:631825. (PMID: 33927588)
Molecules. 2021 Mar 04;26(5):. (PMID: 33806413)
Int J Mol Sci. 2022 Dec 02;23(23):. (PMID: 36499512)
J Toxicol. 2011;2011:405194. (PMID: 21776259)
Antioxidants (Basel). 2020 May 05;9(5):. (PMID: 32380763)
Biology (Basel). 2021 Apr 29;10(5):. (PMID: 33946669)
Cells Tissues Organs. 2018;205(5-6):372-395. (PMID: 30517922)
Psychoneuroendocrinology. 2017 Oct;84:51-60. (PMID: 28654773)
J Nanobiotechnology. 2022 Jun 7;20(1):265. (PMID: 35672765)
Cell Metab. 2022 Mar 1;34(3):408-423.e8. (PMID: 35120590)
Adv Drug Deliv Rev. 2022 May;184:114197. (PMID: 35288219)
Pharmaceutics. 2022 Nov 16;14(11):. (PMID: 36432668)
Molecules. 2022 Feb 25;27(5):. (PMID: 35268651)
J Biol Chem. 2011 Sep 23;286(38):33203-12. (PMID: 21768092)
Nanoscale Res Lett. 2018 Mar 6;13(1):76. (PMID: 29511878)
An Acad Bras Cienc. 2020 Jun 03;92(2):e20191107. (PMID: 32520220)
Int Heart J. 2023 Mar 31;64(1):60-70. (PMID: 36725079)
J Colloid Interface Sci. 2014 Feb 15;416:119-23. (PMID: 24370410)
Neuroscience. 2022 Jan 15;481:219-231. (PMID: 34843897)
J Nanopart Res. 2023;25(3):43. (PMID: 36875184)
Semin Cell Dev Biol. 2015 Sep;45:24-31. (PMID: 26519113)
Antioxid Redox Signal. 2010 Apr 1;12(7):809-18. (PMID: 19769485)
Biochem Soc Trans. 2016 Apr 15;44(2):452-9. (PMID: 27068954)
Arch Biochem Biophys. 2018 Sep 15;654:126-135. (PMID: 30056076)
Front Neurosci. 2021 Feb 25;15:652099. (PMID: 33732108)
Acta Pharm Sin B. 2020 Feb;10(2):239-248. (PMID: 32082970)
Biomater Sci. 2019 Apr 23;7(5):2174-2190. (PMID: 30900719)
Int J Mol Sci. 2021 Jul 21;22(15):. (PMID: 34360564)
Int J Nanomedicine. 2022 Jan 22;17:299-331. (PMID: 35095273)
Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):591-602. (PMID: 33064168)
Front Pharmacol. 2023 Jan 04;13:1103483. (PMID: 36686647)
Toxicol Pathol. 2005;33(5):570-6. (PMID: 16105800)
Int J Mol Sci. 2023 Oct 19;24(20):. (PMID: 37895024)
Nat Neurosci. 2016 Feb;19(2):182-9. (PMID: 26814587)
Biochem J. 2007 Nov 1;407(3):321-9. (PMID: 17922679)
Sci Rep. 2022 Feb 2;12(1):1710. (PMID: 35110605)
J Nanobiotechnology. 2014 Feb 03;12:5. (PMID: 24491160)
Front Nutr. 2023 Mar 16;10:1136458. (PMID: 37006921)
Neurobiol Learn Mem. 2019 Dec;166:107104. (PMID: 31672630)
Molecules. 2023 Jul 27;28(15):. (PMID: 37570666)
Nanomedicine (Lond). 2012 Aug;7(8):1197-209. (PMID: 22583572)
Nat Neurosci. 2021 Mar;24(3):312-325. (PMID: 33589835)
Int J Mol Sci. 2019 Nov 28;20(23):. (PMID: 31795242)
Int J Mol Sci. 2021 Nov 26;22(23):. (PMID: 34884629)
Int J Mol Sci. 2022 Apr 30;23(9):. (PMID: 35563385)
J Biol Chem. 2015 Nov 20;290(47):28097-28106. (PMID: 26400084)
Circulation. 2018 Mar 20;137(12):e67-e492. (PMID: 29386200)
Biochim Biophys Acta. 2016 Dec;1863(12):2977-2992. (PMID: 27646922)
Curr Mol Med. 2016;16(6):533-44. (PMID: 27211800)
Int J Mol Med. 2008 Feb;21(2):169-79. (PMID: 18204783)
Neurochem Res. 2019 Jul;44(7):1549-1566. (PMID: 31093902)
Int J Pharm. 2017 Aug 7;528(1-2):675-691. (PMID: 28629982)
Neurosci Res. 2021 Sep;170:76-86. (PMID: 33358926)
Endocrinology. 2016 Sep;157(9):3682-95. (PMID: 27501182)
Brain. 2017 Mar 1;140(3):547-554. (PMID: 28052917)
Brain Behav. 2013 Sep;3(5):562-74. (PMID: 24392277)
Front Cell Neurosci. 2020 Mar 19;14:51. (PMID: 32265656)
Mol Neurobiol. 2016 Nov;53(9):5818-5832. (PMID: 26497036)
Antioxid Redox Signal. 2020 Dec 10;33(17):1257-1275. (PMID: 32524825)
Front Cell Neurosci. 2021 Jul 26;15:703810. (PMID: 34381334)
Int J Mol Sci. 2020 Sep 28;21(19):. (PMID: 32998277)
Mol Cell. 2017 Jun 15;66(6):780-788. (PMID: 28622523)
J Biol Chem. 2016 Nov 11;291(46):24036-24040. (PMID: 27645994)
Front Cell Neurosci. 2021 Aug 02;15:704334. (PMID: 34408630)
J Inorg Biochem. 2015 Dec;153:1-12. (PMID: 26398431)
Nanomedicine (Lond). 2008 Oct;3(5):703-17. (PMID: 18817471)
Int J Mol Sci. 2022 Aug 19;23(16):. (PMID: 36012647)
ACS Nano. 2015;9(4):3641-53. (PMID: 25790730)
J Clin Endocrinol Metab. 2014 Aug;99(8):E1556-63. (PMID: 24601690)
PLoS One. 2008 Mar 19;3(3):e1813. (PMID: 18350150)
ACS Nano. 2009 May 26;3(5):1151-9. (PMID: 19397333)
J Neurochem. 2001 Sep;78(6):1389-99. (PMID: 11579147)
Hum Mol Genet. 2015 Apr 1;24(7):1843-55. (PMID: 25452428)
Int J Biol Sci. 2023 May 11;19(9):2695-2710. (PMID: 37324938)
Environ Sci Pollut Res Int. 2020 May;27(14):16159-16166. (PMID: 32107689)
Neurochem Res. 2020 Aug;45(8):1888-1901. (PMID: 32447509)
Int J Mol Sci. 2023 Mar 30;24(7):. (PMID: 37047442)
Orphanet J Rare Dis. 2021 Oct 23;16(1):446. (PMID: 34688299)
Biomedicines. 2021 Apr 27;9(5):. (PMID: 33925613)
Metallomics. 2020 Feb 1;12(2):204-217. (PMID: 31793592)
Int J Mol Sci. 2022 Jul 05;23(13):. (PMID: 35806466)
Ann Neurol. 2009 Jun;65(6):677-86. (PMID: 19557870)
Beilstein J Nanotechnol. 2014 Nov 10;5:2058-69. (PMID: 25551033)
PLoS One. 2016 Sep 22;11(9):e0163372. (PMID: 27656880)
Curr Neuropharmacol. 2016;14(3):282-99. (PMID: 26549649)
Biomed Pharmacother. 2019 Mar;111:802-812. (PMID: 30616079)
IUBMB Life. 2014 Apr;66(4):229-39. (PMID: 24668686)
Theranostics. 2017 Feb 8;7(4):884-898. (PMID: 28382161)
Redox Biol. 2022 Sep;55:102412. (PMID: 35917681)
Glia. 2016 Jul;64(7):1097-123. (PMID: 26852907)
Nano Lett. 2016 May 11;16(5):2916-20. (PMID: 26674672)
Int J Toxicol. 2019 Sep/Oct;38(5):357-384. (PMID: 31462100)
Phosphorus Sulfur Silicon Relat Elem. 2005;180(3-4):647-657. (PMID: 16491141)
Oxid Med Cell Longev. 2021 Mar 17;2021:8857486. (PMID: 33815664)
Epigenetics. 2015;10(3):179-90. (PMID: 25647085)
Free Radic Biol Med. 2018 Nov 1;127:124-133. (PMID: 29481840)
Nanoscale. 2016 Feb 14;8(6):3739-52. (PMID: 26815950)
Front Neurosci. 2021 Mar 08;15:646518. (PMID: 33762907)
Biochemistry. 2009 Sep 8;48(35):8458-65. (PMID: 19650649)
Sci Rep. 2023 Aug 7;13(1):12799. (PMID: 37550353)
معلومات مُعتمدة: 21-75-30009 Russian Science Foundation
فهرسة مساهمة: Keywords: nanomaterials; neuroprotection; selenium; selenium nanoparticles; signaling; stroke
تواريخ الأحداث: Date Created: 20240122 Latest Revision: 20240129
رمز التحديث: 20240129
مُعرف محوري في PubMed: PMC10818530
DOI: 10.3390/nano14020160
PMID: 38251125
قاعدة البيانات: MEDLINE
الوصف
تدمد:2079-4991
DOI:10.3390/nano14020160